In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $26.17 in the prior trading day, Carters Inc (NYSE: CRI) closed at $26.29, up 0.46%. In other words, the price has increased by $0.46 from its previous closing price. On the day, 1.05 million shares were traded. CRI stock price reached its highest trading level at $26.3303 during the session, while it also had its lowest trading level at $25.25.
Ratios:
Our goal is to gain a better understanding of CRI by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.82. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.17.
On April 28, 2025, Barclays started tracking the stock assigning a Underweight rating and target price of $25.
Citigroup Upgraded its Sell to Neutral on November 12, 2024, while the target price for the stock was maintained at $50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 07 ’25 when Jenkins Jeff bought 10,853 shares for $25.52 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRI now has a Market Capitalization of 957802560 and an Enterprise Value of 1743955968. As of this moment, Carters’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.98, and their Forward P/E ratio for the next fiscal year is 11.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.34 while its Price-to-Book (P/B) ratio in mrq is 1.12. Its current Enterprise Value per Revenue stands at 0.616 whereas that against EBITDA is 6.302.
Stock Price History:
The Beta on a monthly basis for CRI is 1.01, which has changed by -0.58793104 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, CRI has reached a high of $71.99, while it has fallen to a 52-week low of $23.38. The 50-Day Moving Average of the stock is -11.26%, while the 200-Day Moving Average is calculated to be -37.50%.
Shares Statistics:
The stock has traded on average 1.65M shares per day over the past 3-months and 1316720 shares per day over the last 10 days, according to various share statistics. A total of 36.47M shares are outstanding, with a floating share count of 35.08M. Insiders hold about 3.71% of the company’s shares, while institutions hold 118.18% stake in the company. Shares short for CRI as of 1753920000 were 4863174 with a Short Ratio of 2.96, compared to 1751241600 on 5003455. Therefore, it implies a Short% of Shares Outstanding of 4863174 and a Short% of Float of 17.5.
Dividends & Splits
In the trailing 12 months, CRI’s forward annual dividend rate was 2.65, compared to 2.65 this year. Against a Trailing Annual Dividend Yield of 0.10126099The stock’s 5-year Average Dividend Yield is 1.66. The current Payout Ratio is 62.52% for CRI, which recently paid a dividend on 2025-06-02 with an ex-dividend date of 2025-06-02. Stock splits for the company last occurred on 2006-06-07 when the company split stock in a 2:1 ratio.
